Port Grimaud Realestate
HomeMoneyBriefing: Why a potential anti-cancer agent stalled in trial…
Money

Briefing: Why a potential anti-cancer agent stalled in trials: New enzyme insights may boost yield and purity

Strategic angle: Researchers at the University of Bayreuth have deciphered key steps in the biosynthetic mechanism of fostriecin, a potential anti-cancer agent.

Editorial StaffMarch 30, 20261 min read

First-time insights into the biosynthetic mechanism of fostriecin.

Research led by Prof. Dr. Frank Hahn at the University of Bayreuth.

New findings may enhance the yield and purity of the compound.